Literature DB >> 31425666

The Number of Injury Events Associated With the Critical Size of Bipolar Bone Defects in Rugby Players With Traumatic Anterior Shoulder Instability.

Yoshinori Hasegawa1, Takayuki Kawasaki1, Shuko Nojiri2, Shogo Sobue1, Takefumi Kaketa1, Yoshinori Gonda1, Yoshiaki Itoigawa3, Kazuo Kaneko1.   

Abstract

BACKGROUND: The size of a glenoid bone defect is responsible for reduction in shoulder stability and is correlated with the number of instability events. Biomechanical studies have suggested that it should be considered concomitantly with the Hill-Sachs lesion as "bipolar" bone defects for assessing structural degradation, but the definitive number of instability events associated with the critical size has not been investigated.
PURPOSE: To (1) confirm that the number of instability events is the predictor of a critical size of bipolar bone defects and (2) demonstrate the cutoff value of the number of instability events for these defects in rugby players with traumatic anterior shoulder instability. STUDY
DESIGN: Cross-sectional study; Level of evidence, 3.
METHODS: One-hundred forty-four rugby players with anterior shoulder instability underwent morphologic evaluation for glenoid and Hill-Sachs lesions by computed tomography and determination of the critical (a glenoid bone defect of ≥25% or an off-track Hill-Sachs lesion) and subcritical (a glenoid bone defect of ≥13.5%) size of bipolar bone defects. In the primary analysis, the prevalence of the critical and subcritical size of bipolar bone defects was investigated. In the secondary analysis, the authors explored the predictors for these bone defects and determined the cutoff value correlating with the critical and subcritical size of bipolar bone defects by applying receiver operating characteristic curves.
RESULTS: The primary analysis revealed that the prevalence of critical and subcritical size of bipolar bone defects was 20.8% and 61.8% of 144 shoulders, respectively. In the secondary analysis, multiple logistic regression analysis demonstrated that the total number of shoulder instability events and dominant shoulder were the significant factors associated with the critical and subcritical size of bipolar bone defects. The cutoff value for the number of instability events that correlated with critical bipolar bone defects was 6 for the dominant and 9 for the nondominant shoulder, whereas it was 4 for the dominant and 5 for the nondominant shoulder for subcritical bipolar bone defects.
CONCLUSION: The number of shoulder instability events and the dominant shoulder were the predictors for the critical and subcritical size of bipolar bone defects for a shoulder with traumatic instability. Four injury events should herald caution when treating rugby players with shoulder instability.

Entities:  

Keywords:  bipolar bone defects; collision athletes; computed tomography; rugby; shoulder; shoulder dislocation

Mesh:

Year:  2019        PMID: 31425666     DOI: 10.1177/0363546519869673

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  3 in total

1.  Effect of quality control circle on nursing in orthopaedic trauma surgery.

Authors:  Jinjiao Yu; Ruijuan Qi; Wenjuan Wang; Ge Jiang; Yan Liu; Weiwei Zhang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

Review 2.  Recurrence in traumatic anterior shoulder dislocations increases the prevalence of Hill-Sachs and Bankart lesions: a systematic review and meta-analysis.

Authors:  Cain Rutgers; Lukas P E Verweij; Simone Priester-Vink; Derek F P van Deurzen; Mario Maas; Michel P J van den Bekerom
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-01-06       Impact factor: 4.114

3.  Anterior and posterior glenoid bone loss in patients receiving surgery for glenohumeral instability is not the same: a comparative 3-dimensional imaging analysis.

Authors:  Justin J Ernat; Petar Golijanin; Annalise M Peebles; Stephanie K Eble; Kaare S Midtgaard; Matthew T Provencher
Journal:  JSES Int       Date:  2022-02-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.